Financials

News Ideas Technicals Forecast

4015 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to JAMJOOM PHARMACEUTICALS FACTORY CO. operating, investing, and financing activities

4015 free cash flow for Q1 24 is -68.48 M SAR. For 2023, 4015 free cash flow was 250.85 M SAR and operating cash flow was 296.03 M SAR.

Q1 '22

Q2 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: SAR

Q1 '22

Q2 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—